LUPKYNIS Drug-use Results Survey
Recruiting · NCT07053891 · Observational (researchers observe without assigning treatment) · Lead sponsor: Otsuka Pharmaceutical Co., Ltd.
View the official record on ClinicalTrials.gov →Interventions studied
Voclosporin (LUPKYNIS)
What this trial is about
The purpose of this study is to survey the safety of LUPKYNIS in patients with lupus nephritis under actual use conditions. In addition, information on efficacy will be collected.
Who can take part
Age range
15 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients who are newly starting administration of LUPKYNIS for lupus nephritis
Where it is running
1 location listed.
- Pharmacovigilance Department - Osaka, Osaka, Japan